Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area cell cycle rock'

Search results for: 'research area cell cycle rock'

Items 61-70 of 184

Page
per page
  1. D4476
    A3342 D4476
     1 Citation
    Target: CK1
    Summary: CK1/ALK5 inhibitor,specific and cell permeable
      insoluble in H2O; ≥19.9 mg/mL
  2. IOWH-032
    A8637 IOWH-032
    Target: CFTR
    Summary: CFTR inhibitor
      ≥21.85 mg/mL
  3. XMD17-109
    A3942 XMD17-109
    Target: ERK
    Summary: ERK-5 inhibitor
      ≥31.95 mg/mL
  4. LGX818
    B1174 LGX818
    Target: Raf
    Summary: RAF inhibitor,potent and selective
      insoluble in EtOH; insoluble in H2O; ≥13.38 mg/mL
  5. C646
    B1577 C646
     1 Citation
    Target: p300
    Summary: HAT p300-CBP inhibitor,cell-permeable
      insoluble in H2O; ≥11.14 mg/mL
  6. DAPT (GSI-IX)
    A8200 DAPT (GSI-IX)
     6 Citation
    Summary: γ-secretase inhibitor,potent and specific
      ≥21.62 mg/mL
  7. SC 144
    A2173 SC 144
     1 Citation
    Target: Glycoproteins
    Summary: Gp130 inhibitor
      insoluble in EtOH; insoluble in H2O; ≥16.1 mg/mL
  8. Pimasertib (AS-703026)
    A5573 Pimasertib (AS-703026)
    Target: MEK
    Summary: MEK1/2 inhibitor
      ≥21.55 mg/mL
  9. Caspase-3/7 Inhibitor I
    A1925 Caspase-3/7 Inhibitor I
     2 Citation
    Target: Caspases
    Summary: Caspase-3/7 inhibitor
      insoluble in H2O; ≥16.2 mg/mL
  10. BMS 309403
    B7794 BMS 309403
     2 Citation
    Target: Fatty-acid-binding proteins (FABPs)
    Summary: FABP4 inhibitor,potent and selective
      insoluble in H2O; ≥18.15 mg/mL

Items 61-70 of 184

Page
per page
Shop By
Now Shopping by
  1. Specificity Selective Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 174item
  2. Natural Products 1 item
  3. Kits 2item
  4. Peptides 1 item
  5. Cell Biology 1 item
  6. Peptides & Proteins 1 item
  7. Lab Reagents 3item
Reversibility
  1. Reversible 19item
  2. Irreversible 7item
Target
  1. Caspases 6item
  2. Cyclin-Dependent Kinases 13item
  3. Proteasome 4item
  4. Cathepsins 1 item
  5. Histone Deacetylases (HDACs) 11item
  6. Inhibitor of apoptosis proteins (IAP) 1 item
  7. Akt 1 item
  8. Bcl-2 2item
  9. PI3K 4item
  10. Raf 1 item
  11. Aurora Kinases 4item
  12. Bcl-xl 1 item
  13. Glycoproteins 1 item
  14. MDM2 1 item
  15. EZH2 3item
  16. mTOR 1 item
  17. AP-1 2item
  18. MMP 1 item
  19. Myosin II ATPases 1 item
  20. FLT3 1 item
  21. GSK-3 4item
  22. LPA Receptors 1 item
  23. P-glycoprotein (P-gp) 3item
  24. PLK 3item
  25. Chk 4item
  26. VEGFR 1 item
  27. PDGFR 2item
  28. c-Kit 1 item
  29. Bromodomain-containing proteins(BRDs) 1 item
  30. Phosphodiesterases (PDEs) 1 item
  31. Hydrolase 1 item
  32. p38 1 item
  33. Bcr-Abl 1 item
  34. MEK 2item
  35. PORCN 1 item
  36. DOT1L 1 item
  37. Glucagon-like peptide 1 (GLP-1) receptors 1 item
  38. Smoothened 2item
  39. Eukaryotic elongation factors 1 item
  40. Ras 1 item
  41. Src 2item
  42. Trk Receptors 2item
  43. STAT 3item
  44. Microtubules/Tubulins 4item
  45. EGFR 4item
  46. Hedgehog 1 item
  47. Reverse Transcriptases 1 item
  48. ROCK 7item
  49. JAK 2item
  50. p300 1 item
  51. Syk 1 item
  52. DNA-PK 1 item
  53. HSP90 1 item
  54. AMPK 2item
  55. CFTR 3item
  56. TNKS 1 item
  57. ErbB 2item
  58. Toll-like receptors (TLRs) 1 item
  59. DNA Methyltransferases 1 item
  60. Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors (HIF-PHIs) 1 item
  61. ERK 1 item
  62. BMI-1 1 item
  63. PKC 1 item
  64. Calpains 1 item
  65. Ca2 /calmodulin-dependent protein kinases (CaMKs) 2item
  66. Lyn 1 item
  67. SGLT 1 item
  68. USP 1 item
  69. LRRK2 1 item
  70. Sphingosine kinases (SphKs) 1 item
  71. GTPases 1 item
  72. Fatty-acid-binding proteins (FABPs) 1 item
  73. Tie-2 1 item
  74. RSK 1 item
  75. Granzyme B 1 item
  76. Free Fatty Acid Receptors 1 item
  77. phosphatases 1 item
  78. Autophagy 2item
  79. ATM/ATR 3item
  80. CK1 1 item
  81. Farnesyl Diphosphate Synthases 1 item
  82. Melatonin Receptors 1 item
  83. Peroxynitrite 1 item
  84. MAGL 1 item
  85. NPY Receptors 1 item
  86. c-Fyn 1 item
  87. Histamine H1 Receptors 2item
  88. TRP Channel 1 item
  89. Apoptosis Inducers 1 item
  90. NO Donors / Precursors 1 item
  91. IL Receptors 1 item
  92. 15-lipoxygenases 1 item
  93. Peptidoglycan synthesis 1 item
  94. O6-methylguanine-DNA-methyl-transferase (MGMT) 1 item
  95. Aldosterone receptor 1 item
  96. DPP-4 1 item
  97. DREADD Ligands 1 item
  98. p53-MDM2 interaction 1 item
  99. c-Fms tyrosine kinase 1 item
  100. Ub-conjugating enzyme (E2) complex 1 item
  101. MSK 1 item
  102. DCLK2 1 item
  103. Lck 1 item
  104. Bcl-w 1 item
  105. FXR 1 item
  106. ATM 1 item
  107. Sirtuin 1 item
  108. PIKfyve 1 item
Reported Experiments
  1. Animal Experiments 156item
  2. Cell Experiments 100item
Related Disease
  1. Acute Myelogenous Leukemia 1 item
  2. Acute Myeloid Leukemia 7item
  3. Autoimmune Diseases 1 item
  4. Bladder Cancer 4item
  5. B-lymphoid Malignancies 1 item
  6. Breast Cancer 34item
  7. Cancer 103item
  8. Cholangiocarcinoma 1 item
  9. Chronic Lymphocytic Leukemia 2item
  10. Colon Cancer 15item
  11. Colon Carcinoma 1 item
  12. Colorectal Cancer 14item
  13. Diabetes 2item
  14. Fungal Infection 1 item
  15. Glioblastoma 7item
  16. Glioma 2item
  17. Hepatocellular Carcinoma 3item
  18. HIV 1 item
  19. Immunosuppressive Therapy 1 item
  20. Inflammatory Diseases 4item
  21. Leukemia 5item
  22. Liver Cancer 2item
  23. Lung Cancer 6item
  24. Lymphoma 5item
  25. Mantle Cell Lymphoma 2item
  26. Medulloblastoma 1 item
  27. Melanoma 11item
  28. Mixed Lineage Leukemia 1 item
  29. Multiple Myeloma 7item
  30. Neuroblastoma 2item
  31. Non-small Cell Lung Cancer 5item
  32. Non-small Cell Lung Carcinoma 1 item
  33. Ovarian Cancer 10item
  34. Pain Relief 1 item
  35. Pancreatic Cancer 11item
  36. Pancreatic Carcinoma 2item
  37. Prostate Cancer 14item
  38. Psoriasis 1 item
  39. Pulmonary Fibrosis 1 item
  40. Renal Cell Carcinoma 2item
  41. Rheumatoid Arthritis 2item
  42. Sleep Disorders 1 item
  43. Type 2 Diabetes 3item